AllianceBernstein
INMB icon

AllianceBernstein’s INmune Bio INMB Stock Holding History

AllianceBernstein’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,950
Closed -$34.2K – 3377
2026
Q1 		$34.2K Hold
21,950
– – ﹤0.01% 3211
2025
Q4 		$34.2K Hold
21,950
– – ﹤0.01% 3220
2025
Q3 		$45.4K Hold
21,950
– – ﹤0.01% 3222
2025
Q2 		$50.7K Buy
+21,950
New +$161K ﹤0.01% 3209

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AllianceBernstein's INMB Position: Q2 2026 in Review

AllianceBernstein sold out of INmune Bio (INMB) in Q2 2026, closing a stake of 21,950 shares — an estimated $34.2K sold.

AllianceBernstein first reported a position in INMB in Q2 2025 and held it in 4 quarters. The position peaked at $50.7K in Q2 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • AllianceBernstein reported no remaining INmune Bio position as of Q2 2026 after selling out during the quarter.
  • AllianceBernstein sold 21,950 INmune Bio shares in Q2 2026, an estimated $34.2K.
  • AllianceBernstein first reported a position in INmune Bio in Q2 2025 and held it in 4 quarters.
  • AllianceBernstein's INmune Bio position peaked at $50.7K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.